Peptides are short chains of amino acid monomers linked by peptide (amide) bonds. The statistic scope in this report is peptides biosimilars.
In 2019, the market size of Peptides Biosimilars is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Peptides Biosimilars.
This report studies the global market size of Peptides Biosimilars, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Peptides Biosimilars sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Sandoz
Pfizer
Teva Pahrmaceutical
Celltrion
Biocon
Amgen
Samsung Biologics
Mylan
Dr. Reddy''s Laboratories
Stada Arzneimittel AG
Market Segment by Product Type
Glucagon
Calcitonin
Market Segment by Application
Oncology
Chronic Diseases
Autoimmune Diseases
Blood Disorders
Growth Hormone Deficiency
Infectious Diseases
Other Diseases
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Peptides Biosimilars status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Peptides Biosimilars manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Peptides Biosimilars are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
In 2019, the market size of Peptides Biosimilars is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Peptides Biosimilars.
This report studies the global market size of Peptides Biosimilars, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Peptides Biosimilars sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Sandoz
Pfizer
Teva Pahrmaceutical
Celltrion
Biocon
Amgen
Samsung Biologics
Mylan
Dr. Reddy''s Laboratories
Stada Arzneimittel AG
Market Segment by Product Type
Glucagon
Calcitonin
Market Segment by Application
Oncology
Chronic Diseases
Autoimmune Diseases
Blood Disorders
Growth Hormone Deficiency
Infectious Diseases
Other Diseases
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Peptides Biosimilars status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Peptides Biosimilars manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Peptides Biosimilars are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Peptides Biosimilars Market Size Growth Rate by Type (2019-2025)
1.3.2 Glucagon
1.3.3 Calcitonin
1.4 Market Segment by Application
1.4.1 Global Peptides Biosimilars Market Share by Application (2019-2025)
1.4.2 Oncology
1.4.3 Chronic Diseases
1.4.4 Autoimmune Diseases
1.4.5 Blood Disorders
1.4.6 Growth Hormone Deficiency
1.4.7 Infectious Diseases
1.4.8 Other Diseases
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peptides Biosimilars Market Size
2.1.1 Global Peptides Biosimilars Revenue 2014-2025
2.1.2 Global Peptides Biosimilars Sales 2014-2025
2.2 Peptides Biosimilars Growth Rate by Regions
2.2.1 Global Peptides Biosimilars Sales by Regions 2014-2019
2.2.2 Global Peptides Biosimilars Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Peptides Biosimilars Sales by Manufacturers
3.1.1 Peptides Biosimilars Sales by Manufacturers 2014-2019
3.1.2 Peptides Biosimilars Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Peptides Biosimilars Revenue by Manufacturers (2014-2019)
3.2.2 Peptides Biosimilars Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Peptides Biosimilars Market Concentration Ratio (CR5 and HHI)
3.3 Peptides Biosimilars Price by Manufacturers
3.4 Key Manufacturers Peptides Biosimilars Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Peptides Biosimilars Market
3.6 Key Manufacturers Peptides Biosimilars Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Glucagon Sales and Revenue (2014-2019)
4.1.2 Calcitonin Sales and Revenue (2014-2019)
4.2 Global Peptides Biosimilars Sales Market Share by Type
4.3 Global Peptides Biosimilars Revenue Market Share by Type
4.4 Peptides Biosimilars Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Peptides Biosimilars Sales by Application
6 United States
6.1 United States Peptides Biosimilars Breakdown Data by Company
6.2 United States Peptides Biosimilars Breakdown Data by Type
6.3 United States Peptides Biosimilars Breakdown Data by Application
7 European Union
7.1 European Union Peptides Biosimilars Breakdown Data by Company
7.2 European Union Peptides Biosimilars Breakdown Data by Type
7.3 European Union Peptides Biosimilars Breakdown Data by Application
8 China
8.1 China Peptides Biosimilars Breakdown Data by Company
8.2 China Peptides Biosimilars Breakdown Data by Type
8.3 China Peptides Biosimilars Breakdown Data by Application
9 Rest of World
9.1 Rest of World Peptides Biosimilars Breakdown Data by Company
9.2 Rest of World Peptides Biosimilars Breakdown Data by Type
9.3 Rest of World Peptides Biosimilars Breakdown Data by Application
9.4 Rest of World Peptides Biosimilars Breakdown Data by Countries
9.4.1 Rest of World Peptides Biosimilars Sales by Countries
9.4.2 Rest of World Peptides Biosimilars Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Sandoz
10.1.1 Sandoz Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Peptides Biosimilars
10.1.4 Peptides Biosimilars Product Introduction
10.1.5 Sandoz Recent Development
10.2 Pfizer
10.2.1 Pfizer Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Peptides Biosimilars
10.2.4 Peptides Biosimilars Product Introduction
10.2.5 Pfizer Recent Development
10.3 Teva Pahrmaceutical
10.3.1 Teva Pahrmaceutical Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Peptides Biosimilars
10.3.4 Peptides Biosimilars Product Introduction
10.3.5 Teva Pahrmaceutical Recent Development
10.4 Celltrion
10.4.1 Celltrion Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Peptides Biosimilars
10.4.4 Peptides Biosimilars Product Introduction
10.4.5 Celltrion Recent Development
10.5 Biocon
10.5.1 Biocon Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Peptides Biosimilars
10.5.4 Peptides Biosimilars Product Introduction
10.5.5 Biocon Recent Development
10.6 Amgen
10.6.1 Amgen Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Peptides Biosimilars
10.6.4 Peptides Biosimilars Product Introduction
10.6.5 Amgen Recent Development
10.7 Samsung Biologics
10.7.1 Samsung Biologics Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Peptides Biosimilars
10.7.4 Peptides Biosimilars Product Introduction
10.7.5 Samsung Biologics Recent Development
10.8 Mylan
10.8.1 Mylan Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Peptides Biosimilars
10.8.4 Peptides Biosimilars Product Introduction
10.8.5 Mylan Recent Development
10.9 Dr. Reddy''s Laboratories
10.9.1 Dr. Reddy''s Laboratories Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Peptides Biosimilars
10.9.4 Peptides Biosimilars Product Introduction
10.9.5 Dr. Reddy''s Laboratories Recent Development
10.10 Stada Arzneimittel AG
10.10.1 Stada Arzneimittel AG Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Peptides Biosimilars
10.10.4 Peptides Biosimilars Product Introduction
10.10.5 Stada Arzneimittel AG Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Peptides Biosimilars Sales Channels
11.2.2 Peptides Biosimilars Distributors
11.3 Peptides Biosimilars Customers
12 Market Forecast
12.1 Global Peptides Biosimilars Sales and Revenue Forecast 2019-2025
12.2 Global Peptides Biosimilars Sales Forecast by Type
12.3 Global Peptides Biosimilars Sales Forecast by Application
12.4 Peptides Biosimilars Forecast by Regions
12.4.1 Global Peptides Biosimilars Sales Forecast by Regions 2019-2025
12.4.2 Global Peptides Biosimilars Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Peptides Biosimilars Market Size Growth Rate by Type (2019-2025)
1.3.2 Glucagon
1.3.3 Calcitonin
1.4 Market Segment by Application
1.4.1 Global Peptides Biosimilars Market Share by Application (2019-2025)
1.4.2 Oncology
1.4.3 Chronic Diseases
1.4.4 Autoimmune Diseases
1.4.5 Blood Disorders
1.4.6 Growth Hormone Deficiency
1.4.7 Infectious Diseases
1.4.8 Other Diseases
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peptides Biosimilars Market Size
2.1.1 Global Peptides Biosimilars Revenue 2014-2025
2.1.2 Global Peptides Biosimilars Sales 2014-2025
2.2 Peptides Biosimilars Growth Rate by Regions
2.2.1 Global Peptides Biosimilars Sales by Regions 2014-2019
2.2.2 Global Peptides Biosimilars Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Peptides Biosimilars Sales by Manufacturers
3.1.1 Peptides Biosimilars Sales by Manufacturers 2014-2019
3.1.2 Peptides Biosimilars Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Peptides Biosimilars Revenue by Manufacturers (2014-2019)
3.2.2 Peptides Biosimilars Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Peptides Biosimilars Market Concentration Ratio (CR5 and HHI)
3.3 Peptides Biosimilars Price by Manufacturers
3.4 Key Manufacturers Peptides Biosimilars Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Peptides Biosimilars Market
3.6 Key Manufacturers Peptides Biosimilars Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Glucagon Sales and Revenue (2014-2019)
4.1.2 Calcitonin Sales and Revenue (2014-2019)
4.2 Global Peptides Biosimilars Sales Market Share by Type
4.3 Global Peptides Biosimilars Revenue Market Share by Type
4.4 Peptides Biosimilars Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Peptides Biosimilars Sales by Application
6 United States
6.1 United States Peptides Biosimilars Breakdown Data by Company
6.2 United States Peptides Biosimilars Breakdown Data by Type
6.3 United States Peptides Biosimilars Breakdown Data by Application
7 European Union
7.1 European Union Peptides Biosimilars Breakdown Data by Company
7.2 European Union Peptides Biosimilars Breakdown Data by Type
7.3 European Union Peptides Biosimilars Breakdown Data by Application
8 China
8.1 China Peptides Biosimilars Breakdown Data by Company
8.2 China Peptides Biosimilars Breakdown Data by Type
8.3 China Peptides Biosimilars Breakdown Data by Application
9 Rest of World
9.1 Rest of World Peptides Biosimilars Breakdown Data by Company
9.2 Rest of World Peptides Biosimilars Breakdown Data by Type
9.3 Rest of World Peptides Biosimilars Breakdown Data by Application
9.4 Rest of World Peptides Biosimilars Breakdown Data by Countries
9.4.1 Rest of World Peptides Biosimilars Sales by Countries
9.4.2 Rest of World Peptides Biosimilars Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Sandoz
10.1.1 Sandoz Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Peptides Biosimilars
10.1.4 Peptides Biosimilars Product Introduction
10.1.5 Sandoz Recent Development
10.2 Pfizer
10.2.1 Pfizer Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Peptides Biosimilars
10.2.4 Peptides Biosimilars Product Introduction
10.2.5 Pfizer Recent Development
10.3 Teva Pahrmaceutical
10.3.1 Teva Pahrmaceutical Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Peptides Biosimilars
10.3.4 Peptides Biosimilars Product Introduction
10.3.5 Teva Pahrmaceutical Recent Development
10.4 Celltrion
10.4.1 Celltrion Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Peptides Biosimilars
10.4.4 Peptides Biosimilars Product Introduction
10.4.5 Celltrion Recent Development
10.5 Biocon
10.5.1 Biocon Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Peptides Biosimilars
10.5.4 Peptides Biosimilars Product Introduction
10.5.5 Biocon Recent Development
10.6 Amgen
10.6.1 Amgen Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Peptides Biosimilars
10.6.4 Peptides Biosimilars Product Introduction
10.6.5 Amgen Recent Development
10.7 Samsung Biologics
10.7.1 Samsung Biologics Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Peptides Biosimilars
10.7.4 Peptides Biosimilars Product Introduction
10.7.5 Samsung Biologics Recent Development
10.8 Mylan
10.8.1 Mylan Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Peptides Biosimilars
10.8.4 Peptides Biosimilars Product Introduction
10.8.5 Mylan Recent Development
10.9 Dr. Reddy''s Laboratories
10.9.1 Dr. Reddy''s Laboratories Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Peptides Biosimilars
10.9.4 Peptides Biosimilars Product Introduction
10.9.5 Dr. Reddy''s Laboratories Recent Development
10.10 Stada Arzneimittel AG
10.10.1 Stada Arzneimittel AG Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Peptides Biosimilars
10.10.4 Peptides Biosimilars Product Introduction
10.10.5 Stada Arzneimittel AG Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Peptides Biosimilars Sales Channels
11.2.2 Peptides Biosimilars Distributors
11.3 Peptides Biosimilars Customers
12 Market Forecast
12.1 Global Peptides Biosimilars Sales and Revenue Forecast 2019-2025
12.2 Global Peptides Biosimilars Sales Forecast by Type
12.3 Global Peptides Biosimilars Sales Forecast by Application
12.4 Peptides Biosimilars Forecast by Regions
12.4.1 Global Peptides Biosimilars Sales Forecast by Regions 2019-2025
12.4.2 Global Peptides Biosimilars Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
